Biokine Therapeutics Ltd - Company Review
SummaryBiokine Therapeutics Ltd - Company Review
Summary
Biokine Therapeutics Ltd (Biokine) is a biopharmaceutical company that develops novel drugs to treat cancer and inflammation. The company offers clinical and preclinical pipeline products such as BKT140 , BKT130, BKT300, among others. Its products are used for the treatment of various tumors such as multiple myeloma, lymphoma, leukemia, neuroblastoma, retinoblastoma and lung cancer. Biokine develop drugs for cancer patients including anti-cancer and stem cells mobilization drugs. The company intends to develop and implement genomic approaches that will identify new molecular pathways and drugs for various inflammatory diseases such as asthma, atherosclerosis, graft –rejection, AIDS and multiple sclerosis. It operates with other pharmaceutical companies, research organizations and conducts fundraising activities from private and public agencies. Biokine is headquartered in Rehovot, Israel.
This comprehensive company report of Biokine Therapeutics Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.